1-8 of 8
Rita Emili
Close
Sort by
Journal Articles

IHP Interpretation Criteria of Interim-PET Scan Confirms Prognostic Impact In Early Stage Hodgkin Lymphoma Patients without Bulky Disease

Luigi Rigacci, MD, Pier Luigi Zinzani, MD, PhD, Benedetta Puccini, Alessandro Broccoli, Andrea Gallamini, MD, Francesco Merli, MD, Vittorio Stefoni, Caterina Stelitano, Monica Balzarotti, Patrizia Pregno, Ercole Brusamolino, Flavia Salvi, Pietro Maria Stefani, Rosaria Sancetta, Rita Emili, Silvia Tavera, Ida Capodanno, Umberto Vitolo, MD, Cinzia Pellegrini, Anna Marina Liberati, Alberto Bosi
Journal: Blood
Blood (2010) 116 (21): 3890.
https://doi.org/10.1182/blood.V116.21.3890.3890
Published: 2010
Journal Articles

Feasibility and Efficacy of Autologous Stem Cell Transplantation as First-Line Therapy for Peripheral T-Cell Lymphoma: a Single Center Experience

Lorenzo Falchi, Marco Gunnellini, Monica Schippa, Chiara Listorti, Marta Gubbiotti, Rita Emili, Anna Marina Liberati
Journal: Blood
Blood (2008) 112 (11): 4441.
https://doi.org/10.1182/blood.V112.11.4441.4441
Published: 2008
Journal Articles

Early FDG-PET Scan Confirms Its Prognostic Impact Also in Localized Stage, ABVD Treated Hodgkin Lymphoma Patients.

Luigi Rigacci, Benedetta Puccini, Francesco Merli, Caterina Stelitano, Patrizia Pregno, MD, Chiara Fraulini, Flavia Salvi, Rita Emili, Ida Capodanno, Umberto Vitolo, Teodoro Chisesi, Alessandro Levis, Anna Marina Liberati, Alberto Bosi
Journal: Blood
Blood (2008) 112 (11): 1450.
https://doi.org/10.1182/blood.V112.11.1450.1450
Published: 2008
Journal Articles

Persistent Molecular Remission in Patients Treated with Imatinib-IFNa Combination or Imatinib Monotherapy.

Monica Schippa, Enrico Gottardi, Debora Luzi, Lorenzo Falchi, Rita Emili, Ilaria Angeletti, Giorgia Desantis, Erminia Gentileschi, Paola Cerroni, Anna Marina Liberati
Journal: Blood
Blood (2006) 108 (11): 4784.
https://doi.org/10.1182/blood.V108.11.4784.4784
Published: 2006
Journal Articles

Patterns of Clonal Evolution in Ph’-Positive Chronic Myelogenous Leukemia (CML) during Chronic Phase: Overall Incidence, Type, Multiplicity, Development Time, Effect on Subsequent Genetic Instability, Sokal Risk, Type of bcr/abl Transcript and Hematological Evolution.

Debora Luzi, Lorenzo Falchi, Rita Emili, Ilaria Angeletti, Paolo Prontera, Giovanna Venti, Alessandra Bassetti, Marta Gubbiotti, Vincenzo Capparella, Erminia Gentileschi, Emilio Donti, Anna Marina Liberati
Journal: Blood
Blood (2006) 108 (11): 4802.
https://doi.org/10.1182/blood.V108.11.4802.4802
Published: 2006
Journal Articles

Impact of Complete Kariotypic Remission (CKR) and Sokal Risk on Overall Survival in Chronic Myelogenous Leukemia (CML) Patients: A Monocentric Experience.

Lorenzo Falchi, Monica Schippa, Debora Luzi, Rita Emili, Viola Festuccia, Emilia Giugliano, Carmela Ardisia, Annamaria Rauco, Roberta Pace, Emilio Donti, Anna Marina Liberati
Journal: Blood
Blood (2006) 108 (11): 4803.
https://doi.org/10.1182/blood.V108.11.4803.4803
Published: 2006
Journal Articles

Philadelphia Chromosome (Ph’) Secondary Clones in Chronic Myeloid Leukemia (CML) Are Not Indicative of Resistance to IFNa- or Imatinib-Based Treatment Regimens.

Lorenzo Falchi, Paolo Prontera, Debora Luzi, Viola Festuccia, Rita Emili, Enrico Gottardi, Emilio Donti, Anna Marina Liberati
Journal: Blood
Blood (2006) 108 (11): 4806.
https://doi.org/10.1182/blood.V108.11.4806.4806
Published: 2006
Journal Articles

Antitumour Activity of Bortezomib-Pegylated Liposomal Doxorubicine Association: Results of an Ongoing Study in Multiple Myeloma Patients.

Giulia Braccalenti, Pasqualinda Ferrara, Marta Gubbiotti, Paola Cerroni, Rita Emili, Maria Grazia Morandi, Roberta Pace, Anna Marina Liberati
Journal: Blood
Blood (2006) 108 (11): 5116.
https://doi.org/10.1182/blood.V108.11.5116.5116
Published: 2006